GUTS Q4 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3,000-57.1% YoY

Gross Profit

$3,000100.0% margin

Operating Income

-$25M-840333.3% margin

Net Income

-$25M-832333.3% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-78.6%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$108M

Total Liabilities

$80M

Stockholders' Equity

$28M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3,000	$7,000	-57.1%
Gross Profit	$3,000	$5,000	-40.0%
Operating Income	-$25M	-$13M	-94.2%
Net Income	-$25M	-$19M	-30.2%